纸本诊断市场规模、份额和成长分析（按产品、设备类型、应用、最终用户和地区）- 产业预测 2025-2032

2023 年医疗诊断市场规模价值 151.8 亿美元，预计将从 2024 年的 163.8 亿美元成长到 2032 年的 300.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.9%。

纸本诊断市场已实现显着成长，因为它为就地检验提供了一种便捷且经济的选择，尤其是在偏远和资源有限的地区。这些设备利用纸基基底，能够快速且准确地诊断一系列疾病，包括疟疾、爱滋病毒和糖尿病，并且只需要极少的设备和技术专长。生产成本低、易于处理、适用于环境监测和食品安全等应用等优势正在推动需求。其在医疗资源匮乏的地区推行分散式医疗保健解决方案进一步提升了其受欢迎程度。然而，仍存在挑战，例如确保可靠的结果、保持稳定性以及扩大分析物检测范围。持续的研究、改进的製造方法以及医疗保健提供者和行业相关人员之间的合作预计将推动该市场向前发展。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

论文诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 量油尺
• 横向流动化验
• 纸基微流体

纸本诊断市场规模（按设备类型和复合年增长率） (2025-2032)

• 市场概况
• 监控设备
• 诊断设备

论文诊断市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 环境监测
• 临床诊断
• 食品品质检测

论文诊断市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 家庭医疗保健
• 辅助生活保健设施
• 医院和诊所

论文 诊断市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Bio-Rad Laboratories（USA）
• Siemens Healthineers（Germany）
• Abcam Plc（UK）
• Chembio Diagnostic Systems Inc.（USA）
• ACON Laboratories Inc.（USA）
• FFEI（UK）
• ARKRAY Inc.（Japan）
• Creative Diagnostics（USA）
• OraSure Technologies, Inc.（USA）
• Quidel Corporation（USA）
• Thermo Fisher Scientific Inc.（USA）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Roche Diagnostics（Switzerland）
• PerkinElmer Inc.（USA）
• Sysmex Corporation（Japan）
• bioMerieux SA（France）
• Hologic, Inc.（USA）
• Merck KGaA（Germany）

结论和建议

Paper Diagnostics Market size was valued at USD 15.18 billion in 2023 and is poised to grow from USD 16.38 billion in 2024 to USD 30.09 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The paper diagnostics market is witnessing significant growth as an accessible and economical option for point-of-care testing, especially in remote and resource-limited areas. By utilizing paper-based substrates, these devices enable swift and accurate medical diagnoses for various diseases, including malaria, HIV, and diabetes, while requiring minimal equipment and technical expertise. Their advantages, such as low production costs, easy disposal, and versatility in applications like environmental monitoring and food safety, are driving demand. The push for decentralized healthcare solutions in underserved regions further enhances their popularity. However, challenges like ensuring result reliability, maintaining stability, and broadening analyte detection persist. Continued research, improved manufacturing methods, and collaborations among healthcare providers and industry stakeholders are expected to propel this market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Paper Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Paper Diagnostics Market Segments Analysis

Global Paper Diagnostics Market is segmented by Product, Device Type, Application, End-User and region. Based on Product, the market is segmented into Dipsticks, Lateral Flow Assays and Paper-Based Microfluidics. Based on Device Type, the market is segmented into Monitoring Devices and Diagnostic Devices. Based on Application, the market is segmented into Environmental Monitoring, Clinical Diagnostics and Food Quality Testing. Based on End-User, the market is segmented into Home Healthcare, Assisted Living Healthcare Facilities and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Paper Diagnostics Market

The Paper Diagnostics market is driven by the increasing demand for point-of-care testing solutions that are both rapid and cost-effective. These diagnostic tools facilitate immediate diagnosis and treatment, making them particularly valuable in resource-limited or rural areas lacking access to conventional laboratory facilities. By providing a convenient and efficient means of conducting tests on-site, paper diagnostics help bridge the gap in healthcare availability, ensuring timely interventions and improved patient outcomes. The ability to obtain results swiftly and affordably positions this market as a crucial component in the broader healthcare landscape, addressing the needs of underserved populations effectively.

Restraints in the Paper Diagnostics Market

The dependence of healthcare systems on conventional diagnostic methods poses a significant challenge for the paper diagnostics market, as it hinders the integration or substitution of these innovations in certain contexts. Many established healthcare institutions are accustomed to using traditional diagnostic techniques, which can limit their willingness to adopt newer paper-based solutions. This reliance on established practices creates a barrier to the acceptance and implementation of paper diagnostics, ultimately restraining market growth and reducing the potential for innovation in the field. As a result, overcoming this resistance remains a crucial factor for the advancement of paper diagnostics.

Market Trends of the Paper Diagnostics Market

The Paper Diagnostics market is experiencing a notable upswing, propelled by the rise of Point-of-Care Testing (POCT). This trend is largely fueled by the growing demand for rapid and convenient diagnostic solutions that align with the decentralized healthcare model. Paper-based diagnostics offer a crucial advantage by providing immediate results without the need for complex machinery or specialized personnel, making them ideal for various healthcare settings, including remote and resource-limited areas. As healthcare providers increasingly prioritize efficiency and accessibility, the Paper Diagnostics market is expected to flourish, catering to the evolving needs of patients and healthcare professionals alike.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Paper Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Dipsticks
• Lateral Flow Assays
• Paper-Based Microfluidics

Global Paper Diagnostics Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Monitoring Devices
• Diagnostic Devices

Global Paper Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Environmental Monitoring
• Clinical Diagnostics
• Food Quality Testing

Global Paper Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Home Healthcare
• Assisted Living Healthcare Facilities
• Hospitals and Clinics

Global Paper Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Device Type, Application, End-User)
  • US
  • Canada
• Europe (Product, Device Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Device Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Device Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Device Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostic Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FFEI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations